Dna X (SONM) Payables (2018 - 2026)

Dna X's Payables history runs 9 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Payables fell 93.54% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 93.54% YoY) and the FY2025 annual result came in at $4.2 million, up 469.24% from the prior year.
• Payables was $1.1 million for Q1 2026 at Dna X, down from $4.2 million in the prior quarter.
• Across five years, Payables topped out at $25.2 million in Q3 2025 and bottomed at $738000.0 in Q4 2024.
• A 5-year average of $14.1 million and a median of $13.4 million in 2022 frame the typical range for Payables.
• Annual changes were most pronounced in 2024 — Payables tumbled 96.28% — and 2025, when it soared 469.24%.
• Dna X's Payables stood at $21.1 million in 2022, then declined by 6.05% to $19.8 million in 2023, then tumbled by 96.28% to $738000.0 in 2024, then surged by 469.24% to $4.2 million in 2025, then slumped by 73.41% to $1.1 million in 2026.
• Business Quant data shows SONM's Payables at $1.1 million in Q1 2026, $4.2 million in Q4 2025, and $25.2 million in Q3 2025.